Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Drugs Under Experimental and Clinical Research|January 1, 1996
Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acidA M Cuffini, G De Renzi, V Tullio, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 1998
Sub-MICs of sanfetrinem promote the interaction of human polymorphonuclear granulocytes with a multiply resistant strain of Klebsiella pneumoniaeA M Cuffini, V Tullio, A I Palarchio, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|January 1, 1992
[Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria]F Giachino, A Allocco, L Tuninetti, et al.
Mycoses|May 1, 1995
Dermatophytes from cases of skin disease in cats and dogs in Turin, ItalyV F Marchisio, M G Gallo, V Tullio, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1993
Enhanced Staphylococcus aureus susceptibility to immunodefences induced by sub-inhibitory and bactericidal concentrations of imipenemA M Cuffini, V Tullio, A Allocco, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1993
The entry of meropenem into human macrophages and its immunomodulating activityA M Cuffini, V Tullio, A Allocco, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|January 1, 1992
[Urinary infection. II. Comparative in vitro activities of several antibiotic drugs against Gram-positive bacteria]A Allocco, F Giachino, L Tuninetti, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniaeA M Cuffini, V Tullio, A Bonino, et al.
Drugs Under Experimental and Clinical Research|May 25, 1999
Cellular uptake and intraphagocytic activity of the new fluoroquinolone AF 3013 against Klebsiella pneumoniaeV Tullio, A M Cuffini, A Bonino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cellsG Palmieri, V Tullio, A Zingoni, et al.
Pageof 7